# Gain Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:84fcc063-dafa-4196-b33e-a491448edcd1 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/gain-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:53:16.622146+00:00 | | Last reviewed | 2026-10-16T13:53:16.622146+00:00 | ## Identity - Legal name: Gain Therapeutics, Inc. - Display name: Gain Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T23:20:56.455625+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 8 | | Committees | 5 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Claude Nicaise, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:5 - Dov Goldstein, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:6 - Eric Richman: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:7 - Gene Mack: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:8 - Gwen Melincoff: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:9 - Hans Peter Hasler: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:10 - Jeffrey Riley: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:11 - Khalid Islam, Ph.D.: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:12 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Hans Peter Hasler (member, current); Jeffrey Riley (member, current). committee_id=alpha:committee:gain-therapeutics-inc:audit - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Jeffrey Riley (member, current). committee_id=alpha:committee:gain-therapeutics-inc:audit-compensation-chair - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Hans Peter Hasler (member, current). committee_id=alpha:committee:gain-therapeutics-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: Jeffrey Riley. Members: Jeffrey Riley (chair, current); Gwen Melincoff (member, current). committee_id=alpha:committee:gain-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: Hans Peter Hasler. Members: Hans Peter Hasler (chair, current). committee_id=alpha:committee:gain-therapeutics-inc:nominating-and-governance ## Executive leadership - Gene Mack: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:13 - Gianluca Fuggetta: Senior Vice President Finance. Status: current. claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:14 - Melanie Alder: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:15 ## Governance events - CEO_CHANGED: Gene Mack executive of Gain Therapeutics, Inc., effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1f3w86kjt9wq - EXECUTIVE_APPOINTED: Gianluca Fuggetta executive of Gain Therapeutics, Inc., effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1xhslsl7ozsjz - CEO_CHANGED: Melanie Alder executive of Gain Therapeutics, Inc., effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1wb6yotdnfqrd - DIRECTOR_APPOINTED: Gene Mack seat on Gain Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:ocv4sj3c3hk3 - DIRECTOR_APPOINTED: Claude Nicaise, M.D. seat on Gain Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1c149hudxk2le - DIRECTOR_APPOINTED: Dov Goldstein, M.D. seat on Gain Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1pn3w1l189x5kp - DIRECTOR_APPOINTED: Gwen Melincoff seat on Gain Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:g1hofq13mer5i - DIRECTOR_APPOINTED: Hans Peter Hasler seat on Gain Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:2sy3gwipkj1m - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Gain Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:ar6guuhd1mva - COMMITTEE_MEMBER_ADDED: Hans Peter Hasler member of Audit; Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:17m0pxh1d5mmmp - COMMITTEE_MEMBER_ADDED: Gwen Melincoff member of Compensation, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1pjp4vb118n12l - DIRECTOR_APPOINTED: Eric Richman seat on Gain Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:gz9ylngl0a9 - DIRECTOR_APPOINTED: Jeffrey Riley seat on Gain Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:9wvkbkyfzbd0 - COMMITTEE_CREATED: Audit; Compensation · Chair committee of Gain Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:kzl5qwq8svks - COMMITTEE_MEMBER_ADDED: Jeffrey Riley member of Audit; Compensation · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:atc8pccam38 - DIRECTOR_APPOINTED: Khalid Islam, Ph.D. seat on Gain Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:163dokt1l3991l ## Scoped resources - `alpha://company/gain-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record - `alpha://company/gain-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=identity - `alpha://company/gain-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/gain-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=board - `alpha://company/gain-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=committees - `alpha://company/gain-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=leadership - `alpha://company/gain-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=ownership - `alpha://company/gain-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=financials - `alpha://company/gain-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/gain-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=compensation - `alpha://company/gain-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=governance - `alpha://company/gain-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/gain-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=audit - `alpha://company/gain-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=legal - `alpha://company/gain-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=risk - `alpha://company/gain-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=cyber - `alpha://company/gain-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/gain-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=agents - `alpha://company/gain-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/gain-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=events - `alpha://company/gain-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=relationships - `alpha://company/gain-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=assessments - `alpha://company/gain-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:hans-peter-hasler","name":"Hans Peter Hasler"},"source_id":"board_seats"}` - Claim alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jeffrey-riley","name":"Jeffrey Riley"},"source_id":"board_seats"}` - Claim alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:jeffrey-riley","name":"Jeffrey Riley"},"source_id":"board_seats"}` - Claim alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:gwen-melincoff","name":"Gwen Melincoff"},"source_id":"board_seats"}` - Claim alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:hans-peter-hasler","name":"Hans Peter Hasler"},"source_id":"board_seats"}` ## Leadership - Claude Nicaise, M.D.: Director. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb. - Dov Goldstein, M.D.: Director. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb. - Eric Richman: Director. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb. - Gene Mack: Director. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb. - Gwen Melincoff: Director, Compensation. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb. - Hans Peter Hasler: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb. - Jeffrey Riley: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:11. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb. - Khalid Islam, Ph.D.: Director. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:12. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb. - Gene Mack: Chief Executive Officer. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:13. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aaabd8e0f86eee6304945e7b8299b0f80742113f3add30e4975b370e2d6b8667. - Gianluca Fuggetta: Senior Vice President Finance. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:14. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8569193c912f1d9955033c1d14b3f98fc738c1db2b30d4c8eff19fe3c1adc15a. - Melanie Alder: Chief Executive Officer. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:leadership_role:15. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d09e316c4a3eadf51af69406dfe25195f747bbbb52fe743cd2d7324d7506ed5a. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Hans Peter Hasler; Jeffrey Riley. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8. - Compensation: Chair Jeffrey Riley; Members Jeffrey Riley (Chair); Gwen Melincoff. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8. - Nominating and Governance: Chair Hans Peter Hasler; Members Hans Peter Hasler (Chair). Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Gain Therapeutics, Inc.. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:97ae64af5105aa9340142ff0c5f706eba0772d387e4ecd66d78ee24b7eba794d. ## Entity Status - Public listing published. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:97ae64af5105aa9340142ff0c5f706eba0772d387e4ecd66d78ee24b7eba794d. ## Published Fact - US. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:97ae64af5105aa9340142ff0c5f706eba0772d387e4ecd66d78ee24b7eba794d. ## Committee Appointment - Hans Peter Hasler: member, Audit. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8. - Jeffrey Riley: member, Audit. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8. - Jeffrey Riley: chair, Compensation. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8. - Gwen Melincoff: member, Compensation. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8. - Hans Peter Hasler: chair, Nominating and Governance. Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8. ## Security Listing - GANX (NASDAQ). Claim: alpha:claim:company:84fcc063-dafa-4196-b33e-a491448edcd1:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:97ae64af5105aa9340142ff0c5f706eba0772d387e4ecd66d78ee24b7eba794d. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:97ae64af5105aa9340142ff0c5f706eba0772d387e4ecd66d78ee24b7eba794d: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/gain-therapeutics-inc). - alpha:projection-evidence:document:8e1d9a8531cbbee684ffb5edd0fa3f504e773c7b52400bc7be43c8496a373eeb: [Gain Therapeutics, Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1819411/000155837025005829/ganx-20250624xdef14a.htm). - alpha:projection-evidence:document:aaabd8e0f86eee6304945e7b8299b0f80742113f3add30e4975b370e2d6b8667: [GANX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1819411/000110465926035188/ganx-20251231x10k.htm). - alpha:projection-evidence:document:8569193c912f1d9955033c1d14b3f98fc738c1db2b30d4c8eff19fe3c1adc15a: [GANX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1819411/000110465926035188/ganx-20251231x10k.htm). - alpha:projection-evidence:document:d09e316c4a3eadf51af69406dfe25195f747bbbb52fe743cd2d7324d7506ed5a: [GANX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1819411/000110465926035188/ganx-20251231x10k.htm). - alpha:projection-evidence:b395c795c6da072533d7a71120f6f615bc8050c9ab8b99cf43da5a7961ba41a8: [Audit](https://www.sec.gov/Archives/edgar/data/1819411/000155837025005829/ganx-20250624xdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/gain-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/gain-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/gain-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/gain-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T23:20:56.257706+00:00; recorded 2026-10-16T23:20:56.257706+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.